HomeZVRA • NASDAQ
add
Zevra Therapeutics Inc
Previous close
$7.20
Day range
$7.32 - $7.90
Year range
$3.89 - $8.81
Market cap
409.89M USD
Avg Volume
1.00M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | 4.45M | -47.47% |
Operating expense | 24.67M | 75.66% |
Net income | -19.92M | -674.39% |
Net profit margin | -447.85 | -1,374.16% |
Earnings per share | -0.48 | -220.00% |
EBITDA | -22.23M | -260.11% |
Effective tax rate | -0.35% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 49.26M | -43.62% |
Total assets | 144.41M | 36.86% |
Total liabilities | 111.93M | 202.36% |
Total equity | 32.48M | — |
Shares outstanding | 52.62M | — |
Price to book | 9.35 | — |
Return on assets | -40.24% | — |
Return on capital | -64.29% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -19.92M | -674.39% |
Cash from operations | -19.11M | -119.54% |
Cash from investing | -129.00K | -100.38% |
Cash from financing | 15.33M | 1,511.99% |
Net change in cash | -3.59M | -113.80% |
Free cash flow | -12.93M | -77.59% |
About
Founded
2006
Website
Employees
67